National Institutes of Health

With pilot run ending, top marks for LI Bioscience Hub

By GREGORY ZELLER // The Long Island Bioscience Hub is making the grade, according to a report card prepared by independent evaluators. Since launching in 2015, the LIBH – a National Institutes of Health effort uniting Stony Brook University, Brookhaven National Laboratory, Cold Spring Harbor Laboratory and Northwell Health’s Feinstein Institute for Medical Research – has trained hundreds of innovators, helped fund dozens of technology-development projects and assisted the formation of numerous startup companies and…


See you in September (not): Stanley stuns SBU, SUNY

By GREGORY ZELLER // From the Didn’t See That Coming file comes the sudden departure of Stony Brook University President Samuel Stanley Jr., who has resigned his position and will step down July 31. Stanley, who become SBU’s fifth president in July 2009, will become the 21st president of Michigan State University, according to several news reports. His decision – which follows a decade-long tenure ripe with physical expansion and award-winning faculty research – has…


Feinstein stimulates talk of an arthritis breakthrough

By GREGORY ZELLER // An encouraging new study out of the Feinstein Institute for Medical Research says noninvasive bioelectronic stimulation – administered through the outer ear – can effectively reduce symptoms of rheumatoid arthritis. The potentially quantum leap for the treatment of RA and other inflammatory diseases was reported Tuesday in Bioelectronic Medicine, an open-access journal aggregating articles and data from across a dozen-plus basic and clinical disciplines, including biochemistry, neuroscience, bioengineering, artificial intelligence and…


How to build a better med-tech entrepreneur

By GREGORY ZELLER // One of this generation’s commercialization aces says Long Island’s next crop of healthcare visionaries has got the goods. They’re not ready for prime time. Only some have advanced as far as prototyping. But the medical technology (and the creativity) are off the charts, according to Gregory Montalbano, a principal executive at Smithtown-based MIDI Medical Product Development who, for the third straight year, was invited to consult students under the tutelage of…


No. 371: On Hollywood Whisky, organic sweeteners, zero-calorie chocolate and other tasty matters

  Welcome to Friday: You’ve done it, dear reader – the first full workweek of 2019 is just about in the books, and a very welcomed weekend is upon us. It’s Jan. 11 out there, and yes, Grand Canyon National Park – which today celebrates the 111th anniversary of Teddy Roosevelt declaring the canyon a national monument – is open, despite the partial federal government shutdown. Code maker: Today is also an important anniversary for…


NIH gets behind new Feinstein Institute sepsis study

By GREGORY ZELLER // A five-year National Institutes of Health grant will pack the protein into a new Long Island sepsis study. Monowar Aziz, an assistant professor at the Manhasset-based Feinstein Institute for Medical Research, will apply the $1.68 million award to his work examining protein’s role in inflammation and injury in due to sepsis, a body-wide immune system reaction to infection. Sepsis is a sinister opponent, causing nearly half-a-million U.S. deaths annually and leaving…


NIH to Feinstein: Stick out that chest (bioelectrically)

By GREGORY ZELLER // With new treatments for obesity, heart failure and a host of other conditions in sight, a Feinstein Institute researcher will zero in on specific abdominal targets in a new “precision bioelectronic medicine” study. North Shore University Hospital and Long Island Jewish Medical Center Chief of Gastroenterology Larry Miller, who also directs the Gastroenterology Laboratory at the Feinstein Institute for Medical Research, has received a $1.4 million National Institutes of Health grant…


At LineaRX, putting the horsepower behind the CAR T

By GREGORY ZELLER // Marking a big step in the war against cancer, a Stony Brook-based startup has initiated pre-clinical development of a non-viral, plasmid-free chimeric antigen receptor modified T-cell manufacturing platform. In English: A novel platform designed to develop and manufacture new pharmaceutical treatments, including treatments for different forms of cancer. The tech comes from LineaRx Inc., a wholly owned subsidiary that officially spun off from Stony Brook-based Applied DNA Sciences in September. Noting…


At NYIT, a new doctorate in the house (and first PhD)

By GREGORY ZELLER // Doctor of Philosophy, we presume? And at the New York Institute of Technology, we presume correctly, now that NYIT has introduced its first-ever PhD program, joining the ranks of higher-learning institutions offering the highest academic degree conferred by a university. President Henry Foley on Friday announced that NYIT’s first Doctor of Philosophy degree program – realized through a combined Doctor of Osteopathic Medicine (D.O.)/Doctor of Philosophy (PhD) degree in Medical and…


In blockchain, best chance to secure scientific data

By HENRY FOLEY // At a recent speech in Virginia, Attorney General Jeff Sessions proclaimed that undocumented immigrants in Arizona were more likely to go to jail than U.S. citizens. His source was a study by the Crime Prevention Research Center. But there was a problem. That study had a fatal flaw that undermined its conclusion. In fact, the majority of literature on the subject actually shows the reverse. This isn’t the only example of…


Feinstein prof snags $3.5M for bladder-cancer effort

By GREGORY ZELLER // The National Institutes of Health is backing a Long Island-based researcher’s efforts to develop a first-of-its-kind care program for post-surgical bladder cancer patients. Michael Diefenbach, a fellow of both the Society of Behavioral Medicine and the Academy of Behavioral Medicine Research and a professor at Northwell Health’s Manhasset-based Feinstein Institute for Medical Research, has earned a five-year, $3.5 million grant from the NIH’s National Cancer Institute. The funds will be used…


Veteran, rookie SBU researchers earn major honors

By GREGORY ZELLER // Two Stony Brook University researchers – one with an extended résumé of scientific accomplishments, one just warming up – received some major recognition this week. R. Sekar, a professor in the Department of Computer Science in the university’s College of Engineering and Applied Sciences, has been named a SUNY Empire Innovation Professor for his cybersecurity work, which draws on disciplines ranging from programming techniques to networking to artificial intelligence. The SUNY…


Heavy-hitting LI BioMentor Initiative makes it official

By GREGORY ZELLER // A high-octane effort to unite regional bioentrepreneurs with qualified business mentors has formally launched – though the Long Island BioMentor Initiative is already quite busy. The LIBMI officially accepted its first program applications in a “launch event” Thursday morning at the de Seversky Mansion on the New York Institute of Technology’s Old Westbury campus. But the BioMentor Initiative is already a year into a “pilot phase,” according to founding mentor Mark…


No. 284: On plutonium, gun control and the video Q&A, with a Silicon Valley vibe

Friday on my mind: Spend your bread and lose your head, dear readers – you’ve reached another glorious (if wet) weekend. Reward yourself by checking out Eater’s list of highly binge-able TV options, the perfect cure for soggy Saturdays and soaked Sundays. Jiminy Crickets: Happy birthday, “Pinocchio.” The animated Disney classic debuted this date in 1940. Exactly one year later, at Berkeley, Nobel Prize winner Glenn Seaborg produced plutonium. Other debuts: Real boys (and girls)…


No. 279: A new flu review, taking the fight to tuberculosis and why your fish might really like a cold beer

Welcome to Wednesday: And over the hump we go, dear readers, with another week of Long Island innovation and socioeconomic progress in full swing. It was 179 years ago today, on Feb. 7, 1839, when U.S. Senator Henry Clay of Kentucky – warned that a speech would offend abolitionists and pro-slavery factions alike, and could cost him the presidential election – told Congress, “I had rather be right than be president.” The nose knows: Walt…